Birgit Wimmer Named Chairwoman as NOVOMATIC AG Reshapes Supervisory Board

During the General Meeting of NOVOMATIC AG, Birgit Wimmer, MSc., MBA, was designated to the Supervisory Board and subsequently elected as its Chairwoman in the constitutive meeting. She steps into the role of Dr. Bernd Oswald, who served as a Member of the Supervisory Board of NOVOMATIC AG for roughly ten years and will now assume a different role within the company group.

As a co-shareholder, Birgit Wimmer has engaged for many years in key governance roles within the top holding companies, including stints as a Non-Executive Member of the Board of Directors for the Swiss holding companies and as Managing Director of NOVO Invest GmbH. She possesses substantial experience in investment and management, along with numerous years of involvement in the banking sector.

“As Chairwoman of the Supervisory Board, I look forward to working together with my colleagues on both the Supervisory Board and the Executive Board as we help to successfully shape the Group’s strategic and sustainable development,” says Birgit Wimmer.

Dr. Haig Asenbauer, an internationally experienced lawyer with particular expertise in cross-border M&A transactions, company reorganization, and complex investment structures, was elected to serve as Deputy Chairman. Martina Flitsch retains her position as a Member of the Supervisory Board. She has many years of experience in international group structures and in providing strategic and legal support for corporate investments. Dr. Robert Hofians, a recognized finance and capital markets expert who also has extensive experience in the fields of governance and regulation in his roles as a professor and public accountant, also remains a Member of the Supervisory Board.

As of January 1, 2026, the Supervisory Board of NOVOMATIC AG is now composed as follows:

• Birgit Wimmer, MSc., MBA (Chairwoman)
• Dr. Haig Asenbauer (Deputy Chairman)
• Martina Flitsch (Member)
• Dr. Robert Hofians (Member)